NCT06022822 2026-03-18
Placebo-Controlled Trial of Urolithin A Supplementation in Men With Prostate Cancer Undergoing Radical Prostatectomy, URO-PRO Trial
National Cancer Institute (NCI)
Phase 2 Recruiting
Clinical Trials
29 trialsNCT03274687 2026-03-16
Hypofractionated Radiation Therapy or Conventional Radiation Therapy After Surgery in Treating Patients With Prostate Cancer
NRG Oncology
Phase 3 Completed
NCT06654336 2026-03-13
RATIONAL
Ontario Clinical Oncology Group (OCOG)
Phase 2 Recruiting
NCT04288687 2026-03-04
A Trial of Niraparib in Platinum-Sensitive Castration-Resistant Prostate Cancer With DNA Repair Defects
Abramson Cancer Center at Penn Medicine
Phase 2 Completed
NCT04943536 2026-02-27
BiolenRT
Alessa Therapeutics Inc.
Phase 1 Active not recruiting
NCT06257693 2026-02-27
Enzalutamide Implants (Enolen) in Patients With Prostate Cancer
Alessa Therapeutics Inc.
Phase 1 Recruiting
NCT06798558 2026-02-19
Neoadjuvant Lu-177-PSMA-617 in Patients With High Risk Localized Prostate Cancer Undergoing Radical Prostatectomy
Hackensack Meridian Health
Phase 2 Recruiting
NCT04175431 2025-12-18
Prostate Specific Membrane Antigen (PSMA) or (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer, Flu-BLAST-PC Study
University of Washington
Phase 2 Recruiting
NCT05998278 2025-12-18
Personalized Optimization of Systematic Prostate Biopsy
Fujian Medical University Union Hospital
Phase NA Recruiting
NCT04543903 2025-12-02
Neoadjuvant Interstitial Brachytherapy Using Diffusing Alpha Emitters Radiation Therapy in Men With Prostate Cancer
Alpha Tau Medical LTD.
Phase NA Completed
NCT03860961 2025-11-03
Increasing the Dose of Survivorship Care Planning in Improving Care and Outcomes in Prostate Cancer Survivors Receiving Androgen Deprivation Therapy
NRG Oncology
Phase NA Completed
NCT06499870 2025-10-21
Relugolix and Enzalutamide in Combination With Radiation Therapy for the Treatment of Very High Risk Prostate Cancer, OPTIMAL Trial
Northwestern University
Phase 2 Recruiting
NCT07210502 2025-10-07
LDR BURST
Royal Surrey County Hospital NHS Foundation Trust
Phase NA Not yet recruiting
NCT03361735 2025-05-02
Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer
City of Hope Medical Center
Phase 2 Active not recruiting
NCT05665738 2025-04-29
Two-fraction HDR Monotherapy for Localized Prostate Cancer
University of California, San Francisco
Phase NA Recruiting
NCT03654638 2025-04-04
Soy Bread Diet in Improving Immune Function in Participants With Prostate Cancer
Ohio State University Comprehensive Cancer Center
Phase 2 Completed
NCT02254746 2025-02-14
A Phase I-II Dose Escalation Study of Stereotactic Body Radiation Therapy in Patients With Localized Prostate Cancer
Centre Hospitalier Universitaire Vaudois
Phase NA Completed
NCT06736054 2024-12-16
A Phase I Trial of 61Cu-NODAGA-PSMA for Patients with Prostate Cancer
Hoag Memorial Hospital Presbyterian
Phase 1 Recruiting
NCT03762759 2024-05-17
Fluciclovine F18 or Ga68-PSMA PET/CT to Enhance Prostate Cancer Outcomes
Emory University
Phase 2 Active not recruiting
NCT05919524 2023-09-26
SAFO
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
Phase NA Unknown
NCT02624518 2023-04-10
68Ga-RM2 PET/MRI in Biochemically Recurrent Prostate Cancer
Stanford University
Phase 2/3 Completed
NCT02721979 2023-02-09
Apalutamide in Treating Patients With Prostate Cancer Who Are in Active Surveillance
University of Washington
Phase 2 Terminated
NCT04020094 2021-09-22
AtezoVax
University of Utah
Phase 2 Withdrawn
NCT03829930 2021-08-02
Combination of Entinostat and Enzalutamide in Advanced Prostate Cancer
George Washington University
Phase 1 Terminated
NCT02175212 2020-11-20
AADLPC
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
Phase 3 Completed
NCT02168062 2020-07-23
Supportive Therapy in Androgen Deprivation Clinic in Improving Health Outcomes and Managing Side Effects in Patients With Prostate Cancer
University of California, San Francisco
Phase 2 Terminated
NCT03285815 2017-09-18
Prostate Cancer - Localized Adenocarcinoma Proton Therapy
National Cancer Center, Korea
Phase NA Unknown
NCT01219790 2016-04-19
GEMO
Institut Cancerologie de l'Ouest
Phase 1 Completed
NCT00183924 2014-05-22
Estramustine, Docetaxel, and Carboplatin for Patients With Hormone Refractory Prostate Cancer Progressing After Mitoxantrone-Based Chemotherapy.
University of Southern California
Phase 2 Completed